NI
SGMO

Numeric Investors’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Numeric Investors’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-19,100
Closed -$99K – 1139
2017
Q1 		$99K Buy
+19,100
New +$76.6K ﹤0.01% 983
2016
Q4 		– Sell
-1,003,313
Closed -$4.64M – 1165
2016
Q3 		$4.64M Buy
1,003,313
+537,790
+116% +$2.74M 0.04% 329
2016
Q2 		$2.69M Buy
465,523
+357,054
+329% +$2.28M 0.02% 399
2016
Q1 		$656K Sell
108,469
-40,500
-27% -$243K 0.01% 636
2015
Q4 		$1.36M Buy
148,969
+66,519
+81% +$513K 0.01% 519
2015
Q3 		$465K Sell
82,450
-219,100
-73% -$1.81M 0.01% 719
2015
Q2 		$3.34M Buy
301,550
+183,650
+156% +$2.37M 0.04% 316
2015
Q1 		$1.85M Buy
117,900
+79,900
+210% +$1.24M 0.02% 366
2014
Q4 		$578K Sell
38,000
-316,816
-89% -$3.85M 0.01% 582
2014
Q3 		$3.83M Buy
+354,816
New +$4.63M 0.06% 252

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Numeric Investors's SGMO Position: Q2 2017 in Review

Numeric Investors sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2017, closing a stake of 19,100 shares — an estimated $99K sold.

Numeric Investors first reported a position in SGMO in Q3 2014 and held it in 10 quarters. The position peaked at $4.64M in Q3 2016. 143 funds tracked by Wall St. Rank hold SGMO as of Q2 2017.

  • Numeric Investors reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2017 after selling out during the quarter.
  • Numeric Investors sold 19,100 SANGAMO THERAPEUTICS INC shares in Q2 2017, an estimated $99K.
  • Numeric Investors first reported a position in SANGAMO THERAPEUTICS INC in Q3 2014 and held it in 10 quarters.
  • Numeric Investors's SANGAMO THERAPEUTICS INC position peaked at $4.64M in Q3 2016.
  • 143 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2017.

Based on Numeric Investors's 13F filing for Q2 2017, filed 14 Aug 2017.